Call us now :08071793621
Send Inquiry
Send InquiryLuprotas 22.5 mg Injection
Luprotas 22.5 mg Injection Specification
- Salt Composition
- Leuprolide Acetate
- Pacakaging (Quantity Per Box)
- 1 vial per box
- Origin of Medicine
- Synthetic
- Drug Type
- Injection
- Ingredients
- Leuprolide Acetate
- Physical Form
- Liquid
- Function
- Treatment of prostate cancer and hormone-related conditions
- Recommended For
- Patients with advanced prostate cancer or hormone-sensitive conditions
- Dosage
- 22.5 mg
- Dosage Guidelines
- Administered as per physicians recommendation typically every three months through intramuscular injection
- Suitable For
- Adults
- Quantity
- Single dose vial
- Storage Instructions
- Store in a cool dry place away from direct sunlight. Keep out of reach of children.
About Luprotas 22.5 mg Injection
Luprotas 22.5 mg Injection is a liquid formulation containing Leuprolide Acetate, a synthetic medicine used for the treatment of prostate cancer and hormone-related conditions. Each box contains 1 single-dose vial for intramuscular injection every three months, suitable for adults with advanced prostate cancer or hormone-sensitive conditions. It is essential to store the product in a cool, dry place away from direct sunlight and out of reach of children.
FAQs of Luprotas 22.5 mg Injection:
Q: What is the recommended dosage of Luprotas 22.5 mg Injection?
A: The recommended dosage of Luprotas 22.5 mg Injection is typically administered every three months as per the physicians recommendation through intramuscular injection.Q: What is the salt composition of Luprotas 22.5 mg Injection?
A: The salt composition of Luprotas 22.5 mg Injection is Leuprolide Acetate.Q: Who is Luprotas 22.5 mg Injection suitable for?
A: Luprotas 22.5 mg Injection is suitable for adults with advanced prostate cancer or hormone-sensitive conditions.Q: How should Luprotas 22.5 mg Injection be stored?
A: Luprotas 22.5 mg Injection should be stored in a cool, dry place away from direct sunlight and kept out of reach of children.Q: What is the function of Luprotas 22.5 mg Injection?
A: Luprotas 22.5 mg Injection is used for the treatment of prostate cancer and hormone-related conditions.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Anti-Cancer Category
Egsure 1 mg Tablet
Drug Type : Tablet, Other
Dosage : 1 mg as prescribed by the physician
Recommended For : Patients with type 2 diabetes
Suitable For : Adults
Physical Form : Other, Solid
Ingredients : Exenatide 1 mg
Enfiera 100 mg Injection
Drug Type : Injection
Dosage : 100 mg per administration
Recommended For : Patients with conditions requiring Enfierabased treatment
Suitable For : Adults
Physical Form : Liquid
Ingredients : Enfiera 100 mg
Samenza Capsule
Drug Type : Other, Capsule
Dosage : One capsule daily
Recommended For : Individuals with vitamin and mineral deficiencies low energy levels
Suitable For : Adults
Physical Form : Capsule, Other
Ingredients : Ginseng Multivitamins Multiminerals
Doxorex 10 mg Injection
Drug Type : Other, Anticancer Drug
Dosage : 10 mg
Recommended For : Individuals diagnosed with specific types of cancer as per medical prescription.
Suitable For : Other, Adults and elderly patients
Physical Form : Other, Injection
Ingredients : Doxorubicin Hydrochloride
Send InquiryOur Products
- Alzheimers
- Anti-Cancer
- Anti-Fungal
- Anti-Viral
- Arthritis
- Blood Disorder
- Bone Disease
- Bone Marrow Disorder
- Bowel Disease
- Critical Care
- Gynaecology
- Liver Disease
- Lung Disease
- Macular Degeneration
- Multiple Sclerosis
- Nausea
- Nephrology
- Organ Transplant
- Orthostatic Hypotension
- Osteoporsis
- Psoriasis
- Skin Disorder
- Vaccines
- Pharmaceutical Injection
- Enoxaparin Sodium Medicine
- Oral Suspension
- Pharmaceutical Tablets
- Allopathic Medicine
229, Metro Mall, Bapa Sitaram Chawk, Opp. RAF Camp, S.P. Ring Road, Vastral, Ahmedabad - 382418, Gujarat, India
Dr. Harsh M Patel
(Director)
Mobile :08071793621
Send Inquiry
Send SMS
Developed and Managed by Infocom Network Private Limited.
